These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12395671)

  • 1. Is TMP-SMX the best first choice for uncomplicated cystitis in women?
    Hegmann T
    JAAPA; 2002 Sep; 15(9):60-2, 64. PubMed ID: 12395671
    [No Abstract]   [Full Text] [Related]  

  • 2. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.
    Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W;
    Clin Infect Dis; 2002 May; 34(9):1165-9. PubMed ID: 11941541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic failure with trimethoprim+sulfamethoxazole in uncomplicated acute bacterial cystitis and pyelonephritis in women with resistant bacteria].
    Høiby N; Tvede M
    Ugeskr Laeger; 2002 Sep; 164(40):4672-3. PubMed ID: 12380122
    [No Abstract]   [Full Text] [Related]  

  • 4. Addressing antibiotic resistance.
    Gupta K
    Dis Mon; 2003 Feb; 49(2):99-110. PubMed ID: 12601340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
    Brown PD; Freeman A; Foxman B
    Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy.
    Hooton TM; Besser R; Foxman B; Fritsche TR; Nicolle LE
    Clin Infect Dis; 2004 Jul; 39(1):75-80. PubMed ID: 15206056
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro resistance of E coli to TMP/SMX and clinical failure.
    Postgrad Med; 2001 Aug; 110(2 Suppl):9-10; discussion 26-7. PubMed ID: 19667570
    [No Abstract]   [Full Text] [Related]  

  • 8. Increasing in vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):5-8; discussion 26-7. PubMed ID: 19667569
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical implications. In vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis.
    Colgan R; Johnson JR; Kuskowski M; Gupta K
    Antimicrob Agents Chemother; 2008 Mar; 52(3):846-51. PubMed ID: 18086847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised comparison of single-dose vs. three-day and ten-day therapy with trimethoprim-sulfamethoxazole for acute cystitis in women.
    Gossius G; Vorland L
    Scand J Infect Dis; 1984; 16(4):373-9. PubMed ID: 6396834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
    Guneysel O; Onur O; Erdede M; Denizbasi A
    J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary tract infection: traditional pharmacologic therapies.
    Nicolle LE
    Dis Mon; 2003 Feb; 49(2):111-28. PubMed ID: 12601341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women.
    Gupta K; Hooton TM; Roberts PL; Stamm WE
    Arch Intern Med; 2007 Nov; 167(20):2207-12. PubMed ID: 17998493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical practice. Acute uncomplicated urinary tract infection in women.
    Fihn SD
    N Engl J Med; 2003 Jul; 349(3):259-66. PubMed ID: 12867610
    [No Abstract]   [Full Text] [Related]  

  • 16. [Single day treatment in acute cystitis].
    Yamaguchi K; Kawaguchi K
    Hinyokika Kiyo; 1988 May; 34(5):811-3. PubMed ID: 3051939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of the efficacy of a new form of citrated nalidixic acid and of co-tromoxazole in the treatment of uncomplicated cystitis].
    Van Erps P; Denis L
    Acta Urol Belg; 1982; 50(3):376-83. PubMed ID: 6983246
    [No Abstract]   [Full Text] [Related]  

  • 18. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis.
    Le TP; Miller LG
    Clin Infect Dis; 2001 Sep; 33(5):615-21. PubMed ID: 11486284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escherichia coli resistance in uncomplicated urinary tract infection: a model for determining when to change first-line empirical antibiotic choice.
    Perfetto EM; Gondek K
    Manag Care Interface; 2002 Jun; 15(6):35-42. PubMed ID: 12087605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of clinical guidelines.
    Postgrad Med; 2001 Aug; 110(2 Suppl):16-20; discussion 26-7. PubMed ID: 19667572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.